Senior Editor at Nature Reviews Drug Discovery
Sarah Crunkhorn studied for her BSc at the University of Sheffield where she obtained a first in pharmacology. Following her doctoral research in molecular toxicology at the University of Surrey in collaboration with GlaxoSmithKline, where she investigated mechanisms mediating xenobiotic-induced liver growth, she moved to the Joslin Diabetes Centre, Harvard Medical School, Boston, USA, for her postdoctoral research. There she carried out studies aimed to identify novel molecular mechanisms of thiazolidinedione action in humans, and explored the mechanistic role of obesity and overnutrition in modulating muscle gene expression important in the pathophysiology of insulin resistance and type 2 diabetes. She joined Nature Reviews Drug Discovery as an Associate Editor in May 2007. Sarah is based in Boston, USA.
Visit website: https://muckrack.com/sarah-crunkhorn-2
See also: Nature - Scientific journal covering research from a variety of academic disciplines, mostly in science and technology
Articles written by Sarah Crunkhorn
Inhibition of mitochondrial DNA might suppress tumour growth
Nature - 04-Jan-2021
IMTs degraded 1 in 3 cancer cell lines in vitro, and early promise in miceRead more...